Therapy for malignant astrocytomas at UCSF has been surgery followed by adjuvant radiation therapy and chemotherapy. This proposal uses a genetic approach for malignant astrocytoma evaluation and treatment. We target radiation therapy for analysis because it is the most successful of the adjuvant therapies, and because there are three clear groups of patients: those whose tumors progress through their radiation therapy, patients whose tumors stabilize during radiation therapy, and those whose tumors decrease in size. We hypothesize that a tumor's radiation sensitivity depends upon genetic factors. Thus, the loss or gain of genetic material at any locus that determines radiation sensitivity should influence how a tumor responds to radiation. Because there are many possible sites for genetic regulation of radiation response, the first stage of the proposal encompasses several studies of primary astrocytic tumors and cell lines to determine a broad range of genetic pathology in astrocytic brain tumors. This knowledge of genetic alterations in different grades of astrocytic neoplasms should lead to an understanding of which lesions are associated with initiation and which are associated with progression. In the second stage, we will ask whether any of these lesions contribute to clinical radiation response in patients.
The specific aims are: 1) to identify and map regions of loss or gain in DNA from glioma cell lines, primary human gliomas, and primary and recurrent malignant glioma pairs; 2) to compare radiation- sensitive and radiation-resistant tumors for losses and gains of genetic material at loci defined in Aim 1; and, 3) to correlate this genetic data obtained in Aims 1 and 2 with clinical and laboratory observations using the Core database.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA013525-26
Application #
6268686
Study Section
Project Start
1998-06-08
Project End
2000-09-30
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
26
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Rodriguez, Fausto J; Tihan, Tarik; Lin, Doris et al. (2014) Clinicopathologic features of pediatric oligodendrogliomas: a series of 50 patients. Am J Surg Pathol 38:1058-70
Chang, Susan M; Parney, Ian F; Huang, Wei et al. (2005) Patterns of care for adults with newly diagnosed malignant glioma. JAMA 293:557-64
Parney, Ian F; Kunwar, Sandeep; McDermott, Michael et al. (2005) Neuroradiographic changes following convection-enhanced delivery of the recombinant cytotoxin interleukin 13-PE38QQR for recurrent malignant glioma. J Neurosurg 102:267-75
Prados, Michael D; Seiferheld, Wendy; Sandler, Howard M et al. (2004) Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404. Int J Radiat Oncol Biol Phys 58:1147-52
Levin, Victor A; Hess, Kenneth R; Choucair, Ali et al. (2003) Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas. Clin Cancer Res 9:981-90
McKnight, Tracy R; von dem Bussche, Mary H; Vigneron, Daniel B et al. (2002) Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence. J Neurosurg 97:794-802
Hamel, W; Zirkel, D; Mehdorn, H M et al. (2001) (E)-5-(2-bromovinyl)-2'-deoxyuridine potentiates ganciclovir-mediated cytotoxicity on herpes simplex virus-thymidine kinase--expressing cells. Cancer Gene Ther 8:388-96
Simmons, M L; Lamborn, K R; Takahashi, M et al. (2001) Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients. Cancer Res 61:1122-8
Hamel, W; Dazin, P; Israel, M A (1996) Adaptation of a simple flow cytometric assay to identify different stages during apoptosis. Cytometry 25:173-81
Hamel, W; Magnelli, L; Chiarugi, V P et al. (1996) Herpes simplex virus thymidine kinase/ganciclovir-mediated apoptotic death of bystander cells. Cancer Res 56:2697-702

Showing the most recent 10 out of 14 publications